Loading company…
Moximed develops implantable devices intended to relieve pain from knee osteoarthritis.
Founded in 2006 in California, Moximed, Inc. develops implantable shock absorbers for knee osteoarthritis. Its products include the MISHA Knee System, intended to reduce pain and improve function, along with clinical research and patient support. In August 2024, the company raised USD 91 million in Series D funding led by Patient Square Capital, LP, with participation from New Enterprise Associates, Future Fund, Advent Life Sciences, Gilde Healthcare Partners, Vertex Ventures HC, GBS Venture Partners, Morgenthaler Ventures, Cormorant Asset Management, and Warren Point Capital.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in